Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Praziquantel ODT vs Cysticide in Healthy Volunteers
NCT02325713Phase 1Completed
- Sponsor
- Merck KGaA
- Start
- Jan 2015
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of praziquantel in schistosomiasis (16 arms), sponsored by Merck KGaA. Primary endpoint: Area Under the Plasma Concentration-time Curve From Time Zero to Infinity at Day 1. Started Jan 2015; status: completed.
02
Drugs
praziquantel
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on NCT02325713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02325713.